Residing in poverty tied to worse breast cancer outcomesResiding in poverty tied to worse breast cancer outcomes
Women residing in persistently impoverished neighborhoods have worse breast cancer outcomes, according to a study published online Aug. 29 in JAMA Network Open.
Ozempic could delay ageing, researchers suggestOzempic could delay ageing, researchers suggest
New studies suggest the weight loss drug could be used to treat a range of issues, including heart failure. New studies suggest the weight loss drug could be used to treat a range of issues, including heart failure.
Obesity Drug Wegovy Prevents Covid Deaths, Study SuggestsObesity Drug Wegovy Prevents Covid Deaths, Study Suggests
People taking Wegovy were not protected from infection. But in a large trial, their death rates were markedly lower, for reasons that are not clear. People taking Wegovy were not protected from infection. But in a large trial, their death rates were markedly lower, for reasons that are not clear.
Medication-related osteonecrosis of the jaw is prevalent in patients with breast cancerMedication-related osteonecrosis of the jaw is prevalent in patients with breast cancer
1. The cumulative incidence of medication-related osteonecrosis of the jaw (MRONJ) in patients with breast cancer bone metastases was much higher compared to the available data reported in the literature thus far. Evidence Rating Level: 2 (Good) MRONJ is a common side effect of antiresorptive therapeutics such as bisphosphonates and denosumab which are used in
The post Medication-related osteonecrosis of the jaw is prevalent in patients with breast cancer first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
Wegovy could prevent COVID-19 deaths, study showsWegovy could prevent COVID-19 deaths, study shows
A new analysis of a clinical trial of semaglutide — the active ingredient in Wegovy — showed that the popular weight loss drug reduced the risk of Covid-19 deaths among patients with heart disease. Read more… A new analysis of a clinical trial of semaglutide — the active ingredient in Wegovy — showed that Read More
Semaglutide reduces COVID-19 related deaths in patients with obesity and cardiovascular diseaseSemaglutide reduces COVID-19 related deaths in patients with obesity and cardiovascular disease
Semaglutide, the popular anti-obesity drug, reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established cardiovascular disease (CVD) without diabetes, according to a new study published in JACC. The results will be published simultaneously with a presentation at the European Society of Cardiology (ESC) Conference 2024 in Read More
Study finds weight loss drug semaglutide reduced COVID-19 related deaths during the pandemicStudy finds weight loss drug semaglutide reduced COVID-19 related deaths during the pandemic
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an international study led by researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, finds. The randomized, controlled SELECT Trial, funded by Novo Nordisk, studied the effect Read More
Ozempic, Wegovy have health benefits beyond weight loss, studies findOzempic, Wegovy have health benefits beyond weight loss, studies find
New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
STAT+: Pharmalittle: We’re reading about Wegovy study results, an Alnylam heart drug, and moreSTAT+: Pharmalittle: We’re reading about Wegovy study results, an Alnylam heart drug, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, is rather modest. We plan to promenade with the official mascots, spend time with our Pharmalot ancestor, and catch up on Read More
Wegovy Protects Against Deadly COVID CasesWegovy Protects Against Deadly COVID Cases
(MedPage Today) — LONDON — The clinical benefits of semaglutide (Wegovy) went beyond expectations in the SELECT trial, given the reductions in non-cardiovascular and infectious disease deaths observed. Among people with overweight or obesity… (MedPage Today) — LONDON — The clinical benefits of semaglutide (Wegovy) went beyond expectations in the SELECT trial, given the Read More